drugset / Trial / NCT00481117
Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes
RandomizedSingle-groupDouble-blindTreatment
Summary
This study intends to evaluate how safe and well tolerated the LY2405319 compound is when given to people for 7 days (in Part 1) and 28 days (in Part 2). This study intends to also determine if there is a positive effect on lowering the level of glucose in people with type 2 diabetes.
Timeline
- Start
- 2008-08
- Primary completion
- —
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2405319 | Unknown | 1 mg | Subcutaneous |
| Subject | LY2405319 | Unknown | 3 mg | Subcutaneous |
| Subject | LY2405319 | Unknown | 10 mg | Subcutaneous |
| Subject | LY2405319 | Unknown | 20 mg | Subcutaneous |